JKT · BMHS.JK
PT Bundamedik Tbk
IDR 195+IDR 2 (+1.04%)
PT Bundamedik Tbk’s quoted price sits in the lower half of its reported 52-week range, 20.73% below the high.
Loading market information…
JKT · IRRA.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Itama Ranoraya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Itama Ranoraya Tbk’s forward annual dividend is IDR 12 per share, paid annual. The forward yield is 3.43% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Itama Ranoraya Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical products; and hospital supplies. It also provides cold chain management, such as cold room, bloodbank, and pharmaceutical refrigerator; critical care; and pharmaceutical supplements, as well as maternal and neonatal care products. In addition, the company leases office space. It sells its products under the oneject, Abbott, Terumo, Medtronic, HMD, BD, Vestfrost, Hemocue, Planmed, Sinmed, Balmed, Zepa, KSM CARE, Trisan Care, GEA, Hologic, IS, Avimac, RadmediX, MTS, and SMAM brands. PT Itama Ranoraya Tbk was founded in 1988 and is based in Jakarta Timur, Indonesia. PT Itama Ranoraya Tbk is a subsidiary of PT Global Dinamika Kencana.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
IDR 195+IDR 2 (+1.04%)
PT Bundamedik Tbk’s quoted price sits in the lower half of its reported 52-week range, 20.73% below the high.
IDR 3,610IDR 0 (0.0%)
PT Merck Tbk’s quoted price sits in the lower half of its reported 52-week range, 19.78% below the high.
IDR 123-IDR 2 (-1.6%)
UBC Medical Indonesia Tbk.’s quoted price sits in the lower half of its reported 52-week range, 52.69% below the high.
IDR 123+IDR 1 (+0.82%)
PT Royal Prima Tbk’s quoted price sits in the upper half of its reported 52-week range, 8.21% below the high.
IDR 64-IDR 4 (-5.88%)
PT Maja Agung Latexindo Tbk’s quoted price sits in the lower half of its reported 52-week range, 44.83% below the high.
IDR 278-IDR 2 (-0.71%)
PT Diagnos Laboratorium Utama Tbk’s quoted price sits in the upper half of its reported 52-week range, 27.23% below the high.
IDR 198IDR 0 (0.0%)
PT Millennium Pharmacon International Tbk’s quoted price sits in the upper half of its reported 52-week range, 13.16% below the high.
IDR 254IDR 0 (0.0%)
PT Phapros, Tbk’s quoted price sits in the lower half of its reported 52-week range, 44.78% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
